CERGUTUZUMAB
UNII O2IF0511E8

Substance Identification & Data

This profile provides standardized clinical and technical data for Cergutuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O2IF0511E8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1622305-37-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
O2IF0511E8
CAS Registry Number
1622305-37-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CERGUTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174781
National Cancer Institute reference terminology for clinical and research data.
USAN ID
DE-102
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cergutuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CERGUTUZUMAB

Common Names & Synonyms

CERGUTUZUMAB [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN MONOCLONAL MAB<CEA> HEAVY CHAIN 1 (HOLE)), DISULFIDE WITH HUMAN MONOCLONAL MAB<CEA> LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN MONOCLONAL MAB<CEA> HEAVY CHAIN 2 (KNOB)), DISULFIDE WITH HUMAN MONOCLONAL MAB<CEA> LIGHT CHAIN

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus